News Breaks |
|
|
| October 9, 2012 |
| 09:22 EDT |  | AKRX | FDA warns Akorn about manufacturing unapproved new drugs
The FDA posted on its website a warning letter sent to Akorn (AKRX) dated October 2. The letter stated Akorn is manufacturing unapproved new drugs in violation of the Federal Food, Drug, and Cosmetic Act. The FDA told Akorn it is manufacturing Pilocarpine Hydrochloride Ophthalmic Solution products or other new drugs without approved applications, and the agency request prompt action.Reference Link |
|
|
News For AKRX From The Last 14 Days Check below for free stories on AKRX the last two weeks. |
|
|
| May 8, 2013 |
| 07:33 EDT |  | AKRX | Akorn sell-off on Q1 results overdone, says Leerink
 Subscribe for More Information |
|
| May 7, 2013 |
| 11:54 EDT | | AKRX | Akorn long-term growth story intact, says Piper Jaffray
Subscribe for More Information |
|
| 09:29 EDT | | AKRX | Akorn guidance likely to pressure shares, says Leerink
Subscribe for More Information |
|
| 09:00 EDT |  | AKRX | Akorn falls 5.9%
Subscribe for More Information |
|
| 06:07 EDT |  | AKRX | Akorn sees FY13 adjusted EPS 53c-55c, consensus 62c
Subscribe for More Information |
|
| 06:07 EDT | | AKRX | Akorn reports Q1 adjusted EPS 13c, consensus 14c
Subscribe for More Information |
|
|
|
|
|
